What can we learn from the ZOOM trial? – Authors’ reply - 02/09/13
Doi : 10.1016/S1470-2045(13)70295-X
Dino Amadori a 
, Laura Mercatali a, Oriana Nanni b, Massimo Aglietta c, Barbara Alessi d, Lorenzo Gianni e, Gabriella Farina f, Fernando Gaion g, Francesco Bertoldo h, Daniele Santini i, Roberta Rondena j, Paola Bogani j, Carla Ida Ripamonti k, Toni Ibrahim a
, Laura Mercatali a, Oriana Nanni b, Massimo Aglietta c, Barbara Alessi d, Lorenzo Gianni e, Gabriella Farina f, Fernando Gaion g, Francesco Bertoldo h, Daniele Santini i, Roberta Rondena j, Paola Bogani j, Carla Ida Ripamonti k, Toni Ibrahim a a Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
b Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
c Oncological Department, Medical Oncology, Institute for Cancer Research and Treatment (IRCCS), Candiolo, Turin, Italy
d Department of Medical Oncology, University Hospital of Udine, Udine, Italy
e Oncology Department, Infermi Hospital, Rimini, Italy
f Department of Medical Oncology, Fatebenefratelli-Oftalmico Hospital, Milan, Italy
g Department of Medical Oncology, ULSS 15, Camposampiero, Italy
h Institute of Internal Medicine, Department of Medicine, University of Verona, Verona, Italy
i Department of Medical Oncology, University Campus Bio-Medico, Rome, Italy
j Novartis Farma, Origgio, Italy
k Supportive Care in Cancer Unit, Department of Hematology and Pediatric Onco-Hematology, National Cancer Institute, Milan, Italy
Le texte complet de cet article est disponible en PDF.
© 2013
Elsevier Ltd. Tous droits réservés.
Vol 14 - N° 10
P. e388-e390 - septembre 2013 Retour au numéro
Article précédent
- What can we learn from the ZOOM trial?
- Stefanie Hayoz, Dirk Klingbiel, Peter Brauchli, Roger von Moos
- Surgery or radiotherapy for early-stage lung cancer—a potential comparison bias
- Paul E Van Schil, Jan Van Meerbeeck
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?